Table 4.

Frequencies of P53 and CD95 polymorphic spots at +72 G/C and −670 A/G respectively in all subjects.

Genotypes/Alleles/models	Controls (n = 80)		SVR (n = 86)		NR (n = 74)
	n	%	n	%	n	%
P53 General genotypes
72 G/G (Arg/Arg)	42	52.5	38	44.2c	24	32.4a
72 G/C (Arg/Pro)	33	41.3	44	51.2c	26	35.2c
72 C/C (Pro/Pro)	5	6.2	4	4.6c	24	32.4a∗,b∗
P53 Alleles frequency
72 G (Arg)	117	73.1	120	69.8c	76	50a
72 C (Pro)	43	26.9	52	30.2c	74	50a
P53 Dominant model
Arg/Arg	42	52.5	38	44.2c	24	32.4a
Arg/Pro + Pro/Pro	38	47.5	48	55.8c	50	67.6a
P53 Recessive model
Arg/Arg + Arg/Pro	75	93.7	82	95.4c	50	67.6a∗,b∗
Pro/Pro	5	6.3	4	4.6c	24	32.4a∗,b∗
CD95 Genotypes
−670 A/A	29	36.3	28	32.6c	8	10.8a,b
−670 A/G	34	42.5	42	48.8c	45	60.8a
−670 G/G	17	21.2	16	18.6c	21	28.4c
CD95 Alleles frequency
−670 A	92	57.5	98	57c	61	41.2c
−670 G	68	42.5	74	43c	87	58.8c
CD95 Dominant model
A/A	29	36.3	28	32.6c	8	10.8a,b
A/G + G/G	51	63.7	58	67.4c	66	89.2a,b
CD95 Recessive model
A/A + A/G	63	78.7	70	81.4c	53	71.6c
G/G	17	21.3	16	18.6c	21	28.4c

n: size of samples.

a/a*: a significant/a high significant correlation when comparing non-responders with controls.

b/b*: a significant/a high significant correlation when comparing non-responders with responders.

c: a non-significant correlation either when comparing non-responders or responders with controls.